Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
111.77
-2.70 (-2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
64
65
Next >
Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows
March 14, 2022
The Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) vaccine is only moderately effective against the omicron variant when tested in children ages 5 to 15....
Via
Benzinga
Vaccine Stocks BioNTech, Moderna Pop On Fourth Dose — But IBD/TIPP Poll Says Few People Care
March 09, 2022
The IBD/TIPP Poll shows Covid has fallen among Americans' priorities.
Via
Investor's Business Daily
BioNTech, Regeneron To Evaluate FixVac-Based Cancer Vaccine/Libtayo Combo In NSCLC
March 08, 2022
BioNTech SE (NASDAQ: BNTX) has expanded its strategic collaboration with Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to its FixVac candidate BNT116...
Via
Benzinga
Benzinga Bulls And Bears Of The Past Week: Shopify, Palantir, Apple, Meta, Twitter, Johnson & Johnson, American Express And More
March 05, 2022
Benzinga has examined the prospects for many investor favorite stocks over the...
Via
Benzinga
Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows
March 03, 2022
According to a large French study, the risk of hospitalization after vaccination with Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine was about five times...
Via
Benzinga
Markets Fall As Russia-Ukraine Tensions Escalate; American Express, Boeing See Sharp Drops
March 01, 2022
U.S. indices finished lower as the Russian invasion of Ukraine continues to escalate. The conflict has weighed on stocks and economic sentiment whi...
Via
Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows
March 01, 2022
According to a published study, Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) two-dose COVID-19 vaccine provided very little protection for...
Via
Benzinga
DarioHealth Enters Into Strategic Agreement With Sanofi U.S.
March 01, 2022
Novel Strategic Agreement focuses on commercial growth for Dario and the development of Digital Health Solutions on Dario’s platform.
Via
Talk Markets
Maravai LifeSciences Rejects Sartorius' $11B Takeover Bid: Reuters
February 28, 2022
Germany-based laboratory equipment supplier Sartorius AG has approached Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) with an $11 billion acquisition offer...
Via
Benzinga
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
Moderna has to focus on the rest of its pipeline to keep MRNA stock relevant and profitable as Covid vaccine revenues taper off by 2023.
Via
InvestorPlace
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
The Centers for Disease Control and Prevention said that younger males should consider waiting longer between doses of Pfizer Inc's (NYSE: PFE) / BioNTech SE...
Via
Benzinga
Where BioNTech Stands With Analysts
February 23, 2022
BioNTech (NASDAQ:BNTX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0...
Via
Benzinga
Blood Clot Risk After First AstraZeneca COVID-19 Shot Very Small - UK Study Shows
February 23, 2022
A large study into rare blood clots linked with AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine found between one and three cases per million, and only after...
Via
Benzinga
BioNTech, Medigene Ink Immunotherapy Pact Against Cancer
February 22, 2022
BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer...
Via
Benzinga
Why Novavax Has Limited Downside from Here
February 21, 2022
As countries potentially adopt a once yearly vaccination booster schedule for Covid-19, you can expect steady earnings for NVAX stock.
Via
InvestorPlace
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
February 18, 2022
Moderna Inc (NASDAQ: MRNA) said it is developing three new vaccines based on the same technology used for its COVID-19 shot, including one for viral infection...
Via
Benzinga
Pfizer/BioNTech's Omicron-Targeted COVID-19 To Miss March Timeline: Reuters
February 17, 2022
Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
Macy's Inc (NYSE:M) retail stores have something for everyo...
Via
Benzinga
Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?
February 17, 2022
Can the formerly red-hot biotech segment return to its previous glory?
Via
Investor's Business Daily
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
By a narrow vote of 50-46, the Senate has confirmed Robert Califf to run the FDA. Califf, who previously served as the FDA commissioner from February 2016 to January...
Via
Benzinga
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage.
Via
InvestorPlace
World Markets News For Monday
February 14, 2022
European markets were down over fear of Ukrainian battles.
Via
Talk Markets
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
COVID-19 vaccine boosters from Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) become less effective after four...
Via
Benzinga
Why Pfizer Shares Are Trading Lower Today
February 14, 2022
Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for...
Via
Benzinga
Large Cap Biopharma- Well Positioned For Choppy Markets
February 14, 2022
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.
Via
Talk Markets
Why BioNTech Shares Are Falling Today
February 14, 2022
BioNTech SE (NASDAQ: BNTX) is trading lower Monday morning after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19...
Via
Benzinga
FDA Postpones Adcomm For Pfizer's COVID-19 Vaccine For Youngest Kids
February 14, 2022
The FDA has postponed the Advisory Committee meeting scheduled for Pfizer Inc (NASDAQ: PFE) / BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine in...
Via
Benzinga
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
February 11, 2022
From
Pfizer Inc.
Via
Business Wire
Menstrual Irregularities Cases After mRNA COVID-19 Vaccine - EMA Reviews Cases
February 11, 2022
The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation after COVID-19 vaccines from ...
Via
Benzinga
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.